Related Experiment Video

Updated: Jul 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Matrix metalloproteases: underutilized targets for drug delivery

Deepali G Vartak1, Richard A Gemeinhart

  • 1Department of Biopharmaceutical Sciences, The University of Illinois, Chicago, IL 60612, USA.

Journal of Drug Targeting
|March 17, 2007
PubMed

Insights

Matrix metalloproteases (MMPs), enzymes overactive in disease, are promising targets for drug delivery systems. Research highlights strategies for utilizing MMPs, but clinical applications require intensified drug delivery efforts.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Delivery Systems

Background:

  • Extracellular molecules are key targets for drug delivery systems.
  • Matrix metalloproteases (MMPs) are extracellular enzymes often overexpressed in pathologies.
  • MMP research has significantly expanded over the past two decades.

Purpose of the Study:

  • To review strategies for utilizing MMPs in targeted drug delivery.
  • To identify critical factors for designing effective MMP-targeted systems.
  • To assess the progress and future directions of MMP-based drug delivery.

Main Methods:

  • Literature review of MMP biology, pathology, and targeting strategies.
  • Analysis of various approaches for employing MMPs in therapeutic delivery.
  • Identification of key design considerations for MMP-targeted systems.

Main Results:

  • Multiple strategies exist for leveraging MMPs to target therapeutic agents.
  • Key factors influencing the success of MMP-targeted drug delivery have been identified.
  • Steady progress has been made in developing MMP-targeted drug delivery.

Conclusions:

  • MMPs represent viable targets for advanced drug delivery systems.
  • Further focused research and development are needed to translate MMP-based drug delivery into clinical practice.
  • Intensified efforts are crucial to bridge fundamental MMP research with clinical applications.

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent06:46

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on: May 8, 2017

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: